{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:57:46Z","timestamp":1791104266986,"version":"4.1.0"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2004,3,31]],"date-time":"2004-03-31T00:00:00Z","timestamp":1080691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,3,31]],"date-time":"2004-03-31T00:00:00Z","timestamp":1080691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Nutr"],"published-print":{"date-parts":[[2004,8,1]]},"DOI":"10.1038\/sj.ejcn.1601952","type":"journal-article","created":{"date-parts":[[2004,3,31]],"date-time":"2004-03-31T09:13:35Z","timestamp":1080724415000},"page":"1095-1109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Multiple sclerosis and vitamin D: an update"],"prefix":"10.1038","volume":"58","author":[{"given":"B M","family":"VanAmerongen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C D","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Lips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C H","family":"Polman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,3,31]]},"reference":[{"key":"BF1601952_CR1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-0447.1960.tb08674.x","volume":"35","author":"ED Acheson","year":"1960","unstructured":"Acheson ED, Bachrach CD & Wright FM (1960): Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation and other variables. Acta Psychiatr. Scand. 35, 132\u2013147.","journal-title":"Acta Psychiatr. Scand."},{"key":"BF1601952_CR2","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1210\/jcem-60-5-960","volume":"60","author":"JS Adams","year":"1985","unstructured":"Adams JS, Singer FR, Gacad MA, Sharma OP, Hayes MJ, Vouros P & Holick MF (1985): Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J. Clin. Endocrinol. Metab. 60, 960\u2013966.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF1601952_CR3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0140-6736(74)92163-1","volume":"2","author":"BW Agranoff","year":"1974","unstructured":"Agranoff BW & Goldberg D (1974): Diet and the geographical distribution of multiple sclerosis. Lancet 2, 1061\u20131066.","journal-title":"Lancet"},{"key":"BF1601952_CR4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/archneur.1974.00490400081010","volume":"31","author":"M Alter","year":"1974","unstructured":"Alter M, Yamour M, Harshe M & Ed M (1974): Multiple sclerosis and nutrition. Arch. Neurol. 31, 267\u2013272.","journal-title":"Arch. Neurol."},{"key":"BF1601952_CR5","first-page":"S217","volume":"3","author":"EP Amento","year":"1988","unstructured":"Amento EP & Cotter AC (1988): 1,25-Dihydroxyvitamin D3 augments antigen presentation by murine monocyte\/macrophages. J. Bone Miner. Res. 3, S217.","journal-title":"J. Bone Miner. Res."},{"key":"BF1601952_CR6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/1531-8249(200002)47:2<276::AID-ANA28>3.0.CO;2-1","volume":"47","author":"DP Auer","year":"2000","unstructured":"Auer DP, Schumann EM, Kumpfel T, Gossl C & Trenkwalder C (2000): Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann. Neurol. 47, 276\u2013277.","journal-title":"Ann. Neurol."},{"key":"BF1601952_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/(SICI)1098-1136(200007)31:1<59::AID-GLIA60>3.0.CO;2-Y","volume":"1","author":"D Baas","year":"2000","unstructured":"Baas D, Prufer K, Ittel ME, Kuchler-Bopp S, Labourdette G, Sarlieve LL & Brachet P (2000): Rat oligodendrocytes express the vitamin D(3) receptor and respond to 1,25-dihydroxyvitamin D(3). Glia 1, 59\u201368.","journal-title":"Glia"},{"key":"BF1601952_CR8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s001980050058","volume":"8","author":"MJ Barger-Lux","year":"1998","unstructured":"Barger-Lux MJ, Heaney RP, Dowell S, Chen TC & Holick MF (1998): Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos. Int. 8, 222\u2013230.","journal-title":"Osteoporos. Int."},{"key":"BF1601952_CR9","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1210\/jcem-57-6-1308","volume":"57","author":"AK Bhalla","year":"1983","unstructured":"Bhalla AK, Amento EP, Clemens TL, Holick MF & Krane SM (1983): Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrinol. Metab. 57, 1308\u20131310.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF1601952_CR10","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.133.4.1748","volume":"133","author":"AK Bhalla","year":"1984","unstructured":"Bhalla AK, Amento EP, Serog B & Glimcher LH (1984): 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J. Immunol. 133, 1748\u20131754.","journal-title":"J. Immunol."},{"key":"BF1601952_CR11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0022-510X(02)00069-2","volume":"206","author":"C Bjartmar","year":"2003","unstructured":"Bjartmar C, Wujek JR & Trapp BD (2003): Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J. Neurol. Sci. 206, 165\u2013171.","journal-title":"J. Neurol. Sci."},{"key":"BF1601952_CR12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ajcn\/45.4.755","volume":"45","author":"RA Bouillon","year":"1987","unstructured":"Bouillon RA, Auwerx JH, Lissens WD & Pelemans WK (1987): Vitamin D status in the elderly: seasonal precursor deficiency causes 1,25-dihydroxycholecalciferol deficiency. Am. J. Clin. Nutr. 45, 755\u2013763.","journal-title":"Am. J. Clin. Nutr."},{"key":"BF1601952_CR13","first-page":"200","volume":"16","author":"R Bouillon","year":"1995","unstructured":"Bouillon R, Okamura WH & Norman AW (1995): Structure\u2013function relationships in the vitamin D endocrine system. Endocr. Rev. 16, 200\u2013257.","journal-title":"Endocr. Rev."},{"key":"BF1601952_CR14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0165-5728(95)00076-E","volume":"61","author":"DD Branisteanu","year":"1995","unstructured":"Branisteanu DD, Waer M, Sobis H, Marcelis S, Vandeputte M & Bouillon R (1995): Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 alpha, 25-(OH)2D3. J. Neuroimmunol. 61, 151\u2013160.","journal-title":"J. Neuroimmunol."},{"key":"BF1601952_CR15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0165-5728(97)00116-1","volume":"79","author":"DD Branisteanu","year":"1997","unstructured":"Branisteanu DD, Mathieu C & Bouillon R (1997): Synergism between sirolimus and 1,25-dihydroxyvitamin D3 in vitro and in vivo. J. Neuroimmunol. 79, 138\u2013147.","journal-title":"J. Neuroimmunol."},{"key":"BF1601952_CR16","first-page":"F157","volume":"277","author":"AJ Brown","year":"1999","unstructured":"Brown AJ, Dusso A & Slatopolsky E (1999): Vitamin D. Am. J. Physiol. 277, F157\u2013175.","journal-title":"Am. J. Physiol."},{"key":"BF1601952_CR17","doi-asserted-by":"crossref","first-page":"7861","DOI":"10.1073\/pnas.93.15.7861","volume":"93","author":"MT Cantorna","year":"1996","unstructured":"Cantorna MT, Hayes CE & DeLuca HF (1996): 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 93, 7861\u20137864.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF1601952_CR18","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/jn\/129.11.1966","volume":"129","author":"MT Cantorna","year":"1999","unstructured":"Cantorna MT, Humpal-Winter J & DeLuca HF (1999): Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. J. Nutr. 129, 1966\u20131971.","journal-title":"J. Nutr."},{"key":"BF1601952_CR19","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.4049\/jimmunol.160.11.5314","volume":"160","author":"MT Cantorna","year":"1998","unstructured":"Cantorna MT, Woodward WD, Hayes CE & DeLuca HF (1998): 1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J. Immunol. 160, 5314\u20135319.","journal-title":"J. Immunol."},{"key":"BF1601952_CR20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00041552-199507000-00005","volume":"4","author":"K Casteels","year":"1995","unstructured":"Casteels K, Bouillon R, Waer M & Mathieu C (1995): Immunomodulatory effects of 1,25-dihydroxyvitamin D3. Curr. Opin. Nephrol. Hypertens. 4, 313\u2013318.","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BF1601952_CR21","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJM199212033272305","volume":"327","author":"MC Chapuy","year":"1992","unstructured":"Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD & Meunier PJ (1992): Vitamin D3 and calcium to prevent hip fractures in the elderly women. N. Engl. J. Med 327, 1637\u20131642.","journal-title":"N. Engl. J. Med"},{"key":"BF1601952_CR22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s001980050030","volume":"7","author":"MC Chapuy","year":"1997","unstructured":"Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S & Meunier PJ (1997): Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos. Int. 7, 439\u2013443.","journal-title":"Osteoporos. Int."},{"key":"BF1601952_CR23","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1359\/jbmr.1998.13.8.1238","volume":"13","author":"VGM Chel","year":"1998","unstructured":"Chel VGM, Ooms ME, Popp-Snijders C, Pavel S, Schothorst AA, Meulemans CCE & Lips P (1998): Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J. Bone Miner. Res. 13, 1238\u20131242.","journal-title":"J. Bone Miner. Res."},{"key":"BF1601952_CR24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/jcem-53-1-139","volume":"53","author":"RW Chesney","year":"1981","unstructured":"Chesney RW, Rosen JF, Hamstra AJ, Smith C, Mahaffey K & DeLuca HF (1981): Absence of seasonal variation in serum concentrations of 1,25-dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer. J. Clin. Endocrinol. Metab. 53, 139\u2013142.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF1601952_CR25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(82)90214-8","volume":"1","author":"TL Clemens","year":"1982","unstructured":"Clemens TL, Adams JS, Henderson SL & Holick MF (1982): Increased skin pigment reduces the capacity of skin to synthesize vitamin D3. Lancet 1, 74\u201376.","journal-title":"Lancet"},{"key":"BF1601952_CR26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/jnnp.62.6.553","volume":"62","author":"A Compston","year":"1997","unstructured":"Compston A (1997): Genetic epidemiology of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 62, 553\u2013561.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BF1601952_CR27","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1210\/jc.2002-021356","volume":"87","author":"P Correa","year":"2002","unstructured":"Correa P, Segersten U, Hellman P, Akerstrom G & Westin G (2002): Increased 25-hydroxyvitamin D3 1alpha-hydroxylase and reduced 25-hydroxyvitamin D3 24-hydroxylase expression in parathyroid tumors\u2014new prospects for treatment of hyperparathyroidism with vitamin D. J. Clin. Endocrinol. Metab. 87, 5826\u20135829.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF1601952_CR28","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.51.4.1161","volume":"51","author":"F Cosman","year":"1998","unstructured":"Cosman F, Nieves J, Komar L, Ferrer G, Herbert J, Formica C, Shen V & Lindsay R (1998): Fracture history and bone loss in patients with MS. Neurology 51, 1161\u20131165.","journal-title":"Neurology"},{"key":"BF1601952_CR29","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI117282","volume":"93","author":"AH Cross","year":"1994","unstructured":"Cross AH, Misko TP, Lin RF, Hickey WF, Trotter JL & Tilton RG (1994): Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93, 2684\u20132690.","journal-title":"J. Clin. Invest."},{"key":"BF1601952_CR30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-5728(00)00242-3","volume":"107","author":"AH Cross","year":"2000","unstructured":"Cross AH, San M, Stern MK, Keeling RM, Salvemini D & Misko TP (2000): A catalyst of peroxynitrite decomposition inhibits murine experimental autoimmune encephalomyelitis. J. Neuroimmunol. 107, 21\u201328.","journal-title":"J. Neuroimmunol."},{"key":"BF1601952_CR31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1172\/JCI1050","volume":"101","author":"D D'Ambrosio","year":"1998","unstructured":"D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, Sinigaglia F & Panina-Bordignon P (1998): Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest. 101, 252\u2013262.","journal-title":"J. Clin. Invest."},{"key":"BF1601952_CR32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/ajcn\/65.1.67","volume":"65","author":"B Dawson-Hughes","year":"1997","unstructured":"Dawson-Hughes B, Harris SS & Dallal GE (1997): Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women. Am. J. Clin. Nutr. 65, 67\u201371.","journal-title":"Am. J. Clin. Nutr."},{"key":"BF1601952_CR33","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1096\/fj.01-0433rev","volume":"15","author":"HF DeLuca","year":"2001","unstructured":"DeLuca HF & Cantorna MT (2001): Vitamin D: its role and uses in immunology. FASEB J. 15, 2579\u20132585.","journal-title":"FASEB J."},{"key":"BF1601952_CR34","unstructured":"DeLuca HF, Hayes CE & Cantorna MT (2000) US5716946: multiple sclerosis treatment.."},{"key":"BF1601952_CR35","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1359\/jbmr.1998.13.4.544","volume":"13","author":"S Docio","year":"1998","unstructured":"Docio S, Riancho JA, Perez A, Olmos JM, Amado JA & Gonzalez-Macias J (1998): Seasonal deficiency of vitamin D in children: a potential target for osteoporosis-preventing strategies? J. Bone Miner. Res. 13, 544\u2013548.","journal-title":"J. Bone Miner. Res."},{"key":"BF1601952_CR36","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1002\/ana.410360705","volume":"36","author":"GC Ebers","year":"1994","unstructured":"Ebers GC (1994): Genetics and multiple sclerosis: an overview. Ann. Neurol. 36, S12\u2013S14.","journal-title":"Ann. Neurol."},{"key":"BF1601952_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-5728(94)90225-9","volume":"54","author":"GC Ebers","year":"1994","unstructured":"Ebers GC & Sadovnick AD (1994): The role of genetic factors in multiple sclerosis susceptibility. J. Neuroimmunol. 54, 1\u201317.","journal-title":"J. Neuroimmunol."},{"key":"BF1601952_CR38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/1531-8249(200008)48:2<271::AID-ANA28>3.0.CO;2-O","volume":"48","author":"AF Embry","year":"2000","unstructured":"Embry AF, Snowdon LR & Vieth R (2000): Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann. Neurol. 48, 271\u2013272.","journal-title":"Ann. Neurol."},{"key":"BF1601952_CR39","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/oxfordjournals.aje.a117704","volume":"142","author":"ML Esparza","year":"1995","unstructured":"Esparza ML, Sasaki S & Kesteloot H (1995): Nutrition, latitude, and multiple sclerosis mortality: an ecologic study. Am. J. Epidemiol. 142, 733\u2013737.","journal-title":"Am. J. Epidemiol."},{"key":"BF1601952_CR40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0003-9861(81)90107-7","volume":"206","author":"RP Esvelt","year":"1981","unstructured":"Esvelt RP & De Luca HF (1981): Calcitroic acid: biological activity and tissue distribution studies. Arch. Biochem. Biophys. 206, 403\u2013413.","journal-title":"Arch. Biochem. Biophys."},{"key":"BF1601952_CR41","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0306-4522(03)00040-X","volume":"118","author":"D Eyles","year":"2003","unstructured":"Eyles D, Brown J, Mackay-Sim A, McGrath J & Feron F (2003): Vitamin D3 and brain development. Neuroscience 118, 641\u2013653.","journal-title":"Neuroscience"},{"key":"BF1601952_CR42","volume-title":"Vitamin D","author":"D Feldman","year":"1997","unstructured":"Feldman D, Glorieux FH & Pike JW eds. (1997): Vitamin D. San Diego: Academic Press."},{"key":"BF1601952_CR43","first-page":"A338","volume":"54","author":"JO Flemming","year":"2000","unstructured":"Flemming JO, Hummel AL, Beinlich BR, Borowski BJ, Peebles T, Colburn M, Cook TD, Wendt GJ & DeLuca HL (2000): Vitamin D treatment of relapsing-remitting multiple sclerosis (RRMS): a MRI-based pilot study. Neurology 54, A338.","journal-title":"Neurology"},{"key":"BF1601952_CR44","unstructured":"Food and Nutrition Board (FNB), Institute of Medicine (1997): Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press."},{"key":"BF1601952_CR45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0140-6736(95)90067-5","volume":"345","author":"DR Fraser","year":"1995","unstructured":"Fraser DR (1995): Vitamin D. Lancet 345, 104\u2013107.","journal-title":"Lancet"},{"key":"BF1601952_CR46","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/oem.57.6.418","volume":"57","author":"DM Freedman","year":"2000","unstructured":"Freedman DM, Dosemeci M & Alavanja MC (2000): Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case\u2013control study based on death certificates. Occup. Environ. Med. 57, 418\u2013421.","journal-title":"Occup. Environ. Med."},{"key":"BF1601952_CR47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(99)00112-4","volume":"166","author":"T Fukazawa","year":"1999","unstructured":"Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Hamada T, Miyasaka K & Tashiro K (1999): Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J. Neurol. Sci. 166, 47\u201352.","journal-title":"J. Neurol. Sci."},{"key":"BF1601952_CR48","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0301-0082(95)80008-V","volume":"47","author":"CR Gale","year":"1995","unstructured":"Gale CR & Martyn CN (1995): Migrant studies in multiple sclerosis. Prog. Neurobiol. 47, 425\u2013448.","journal-title":"Prog. Neurobiol."},{"key":"BF1601952_CR49","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0169-328X(96)00260-4","volume":"45","author":"E Garcion","year":"1997","unstructured":"Garcion E, Nataf S, Berod A, Darcy F & Brachet P (1997): 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Mol. Brain Res. 45, 255\u2013267.","journal-title":"Mol. Brain Res."},{"key":"BF1601952_CR50","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/(SICI)1098-1136(199803)22:3<282::AID-GLIA7>3.0.CO;2-7","volume":"22","author":"E Garcion","year":"1998","unstructured":"Garcion E, Sindji L, Montero-Menei C, Andre C, Brachet P & Darcy F (1998): Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1,25-dihydroxyvitamin D3. Glia 22, 282\u2013294.","journal-title":"Glia"},{"key":"BF1601952_CR51","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00401-002-0663-0","volume":"105","author":"E Garcion","year":"2003","unstructured":"Garcion E, Sindji L, Nataf S, Brachet P, Darcy F & Montero-Menei CN (2003): Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D(3) leads to early effects within the central nervous system. Acta Neuropathol. 105, 438\u2013448.","journal-title":"Acta Neuropathol."},{"key":"BF1601952_CR52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1043-2760(01)00547-1","volume":"13","author":"E Garcion","year":"2002","unstructured":"Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F & Wion D (2002): New clues about vitamin D functions in the nervous system. Trends Endocrinol. Metab. 13, 100\u2013105.","journal-title":"Trends Endocrinol. Metab."},{"key":"BF1601952_CR53","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2265.2001.01160.x","volume":"54","author":"M Gascon-Barre","year":"2001","unstructured":"Gascon-Barre M, Demers C, Ghrab O, Theodoropoulos C, Lapointe R, Jones G, Valiquette L & Menard D (2001): Expression of CYP27A, a gene encoding a vitamin D-25 hydroxylase in human liver and kidney. Clin. Endocrinol. 54, 107\u2013115.","journal-title":"Clin. Endocrinol."},{"key":"BF1601952_CR54","first-page":"703","volume-title":"Immunology of the nervous system","author":"CP Genain","year":"1997","unstructured":"Genain CP & Hauser SL (1997): Autoimmune demyelinating diseases of the central nervous system. In Immunology of the nervous system, eds RW Keane, WF Hickey, pp 703\u2013726. New York: Oxford University Press."},{"key":"BF1601952_CR55","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.1995.03530210037027","volume":"274","author":"FM Gloth III","year":"1995","unstructured":"Gloth III FM, Gundberg CM, Hollis BW, Haddad Jr JG & Tobin JD (1995): Vitamin D deficiency in homebound elderly persons. JAMA 274, 1683\u20131686.","journal-title":"JAMA"},{"key":"BF1601952_CR56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/00207237408709630","volume":"6","author":"P Goldberg","year":"1974","unstructured":"Goldberg P (1974a): Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence (a viewpoint). Part I: sunlight, dietary factors and epidemiology. Int. J. Environ. Studies 6, 19\u201327.","journal-title":"Int. J. Environ. Studies"},{"key":"BF1601952_CR57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00207237408709641","volume":"6","author":"P Goldberg","year":"1974","unstructured":"Goldberg P (1974b): Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence (a viewpoint). Part 2: biochemical and genetic factors. Int. J. Environ. Studies 6, 121\u2013129.","journal-title":"Int. J. Environ. Studies"},{"key":"BF1601952_CR58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0306-9877(86)90010-1","volume":"21","author":"P Goldberg","year":"1986","unstructured":"Goldberg P, Fleming MC & Picard EH (1986): Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med. Hypotheses 21, 193\u2013200.","journal-title":"Med. Hypotheses"},{"key":"BF1601952_CR59","first-page":"11","volume":"44","author":"R Goldman","year":"1984","unstructured":"Goldman R (1984): Introduction of a high phagocytic capability in P388D1, a macrophage-like tumor cell line, by 1a,25-dihydroxyvitamin D3. Cancer Res. 44, 11\u201319.","journal-title":"Cancer Res."},{"key":"BF1601952_CR60","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.4049\/jimmunol.167.4.1945","volume":"167","author":"S Gregori","year":"2001","unstructured":"Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM & Adorini L (2001): Regulatory t cells induced by 1alpha,25-dihydroxyvitamin d(3) and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167, 1945\u20131953.","journal-title":"J. Immunol."},{"key":"BF1601952_CR61","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1073\/pnas.121172198","volume":"98","author":"MD Griffin","year":"2001","unstructured":"Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ & Kumar R (2001): Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. USA 98, 6800\u20136805.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF1601952_CR62","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF01623661","volume":"5","author":"S Guillemant","year":"1995","unstructured":"Guillemant S, Guillemant J & Duntze P (1995): Comparison of the biochemical and hormonal acute effects of calcium salts. Osteoporos. Int. 5, 66\u201367.","journal-title":"Osteoporos. Int."},{"key":"BF1601952_CR63","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s001980050219","volume":"10","author":"J Guillemant","year":"1999","unstructured":"Guillemant J, Taupin P, Le HT, Taright N, Allemandou A, Peres G & Guillemant S (1999): Vitamin D status during puberty in French healthy male adolescents. Osteoporos. Int. 10, 222\u2013225.","journal-title":"Osteoporos. Int."},{"key":"BF1601952_CR64","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/brain\/123.5.968","volume":"123","author":"SR Hammond","year":"2000","unstructured":"Hammond SR, English DR & McLeod JG (2000): The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. Brain 123, 968\u2013974.","journal-title":"Brain"},{"key":"BF1601952_CR65","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4049\/jimmunol.132.3.1276","volume":"132","author":"SL Hauser","year":"1984","unstructured":"Hauser SL, Weiner HL, Che M, Shapiro ME, Gilles F & Letvin NL (1984): Prevention of experimental allergic encephalomyelitis (EAE) in the SJL\/J mouse by whole body ultraviolet irradiation. J. Immunol. 132, 1276\u20131281.","journal-title":"J. Immunol."},{"key":"BF1601952_CR66","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1017\/S0029665100000768","volume":"59","author":"CE Hayes","year":"2000","unstructured":"Hayes CE (2000): Vitamin D: a natural inhibitor of multiple sclerosis. Proc. Nutr. Soc. 59, 531\u2013535.","journal-title":"Proc. Nutr. Soc."},{"key":"BF1601952_CR67","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3181\/00379727-216-44153A","volume":"216","author":"CE Hayes","year":"1997","unstructured":"Hayes CE, Cantorna MT & DeLuca HF (1997): Vitamin D and multiple sclerosis. Proc. Soc. Exp. Biol. Med. 216, 21\u201327.","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"BF1601952_CR68","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/ajcn\/78.5.912","volume":"78","author":"RP Heaney","year":"2003","unstructured":"Heaney RP (2003b): Long-latency deficiency disease: insights from calcium and vitamin D. Am. J. Clin. Nutr. 78, 912\u2013919.","journal-title":"Am. J. Clin. Nutr."},{"key":"BF1601952_CR69","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ajcn\/77.1.204","volume":"77","author":"RP Heaney","year":"2003","unstructured":"Heaney RP, Davies KM, Chen TC, Holick MF & Barger-Lux MJ (2003a): Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 77, 204\u2013210.","journal-title":"Am. J. Clin. Nutr."},{"key":"BF1601952_CR70","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1010015013211","volume":"2","author":"M Hewison","year":"2001","unstructured":"Hewison M, Gacad MA, Lemire J & Adams JS (2001): Vitamin D as a cytokine and hematopoetic factor. Rev. Endocr. Metab. Disord. 2, 217\u2013227.","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"BF1601952_CR71","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1677\/jme.0.0250141","volume":"25","author":"M Hewison","year":"2000","unstructured":"Hewison M, Zehnder D, Bland R & Stewart PM (2000): 1alpha-Hydroxylase and the action of vitamin D. J. Mol. Endocrinol. 25, 141\u2013148.","journal-title":"J. Mol. Endocrinol."},{"key":"BF1601952_CR72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/000456329403100105","volume":"31","author":"TJ Hine","year":"1994","unstructured":"Hine TJ & Roberts NB (1994): Seasonal variation in serum 25-hydroxy vitamin D3 does not affect 1,25-dihydroxy vitamin D. Ann. Clin. Biochem. 31, 31\u201334.","journal-title":"Ann. Clin. Biochem."},{"key":"BF1601952_CR73","first-page":"1876","volume":"46","author":"MF Holick","year":"1987","unstructured":"Holick MF (1987): Photosynthesis of vitamin D in the skin: effect of environmental and life-style variables. Fed. Proc. 46, 1876\u20131882.","journal-title":"Fed. Proc."},{"key":"BF1601952_CR74","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00060793-200202000-00011","volume":"9","author":"MF Holick","year":"2002","unstructured":"Holick MF (2002): Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr. Opin. Endocrinol. Diab. 9, 87\u201398.","journal-title":"Curr. Opin. Endocrinol. Diab."},{"key":"BF1601952_CR75","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.172.4.1025","volume":"172","author":"I Huitinga","year":"1990","unstructured":"Huitinga I, van Rooijen N, de Groot CJ, Uitdehaag BM & Dijkstra CD (1990): Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172, 1025\u20131033.","journal-title":"J. Exp. Med."},{"key":"BF1601952_CR76","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0306-9877(96)90225-X","volume":"46","author":"CD Hutter","year":"1996","unstructured":"Hutter CD & Laing P (1996): Multiple sclerosis: sunlight, diet, immunology and aetiology. Med. Hypotheses 46, 67\u201374.","journal-title":"Med. Hypotheses"},{"key":"BF1601952_CR77","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s000110050360","volume":"47","author":"LL Issa","year":"1998","unstructured":"Issa LL, Leong GM & Eisman JA (1998): Molecular mechanism of vitamin D receptor action. Inflamm. Res. 47, 451\u2013475.","journal-title":"Inflamm. Res."},{"key":"BF1601952_CR78","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/WNL.58.7.1077","volume":"58","author":"J Killestein","year":"2002","unstructured":"Killestein J, Rep MH, Meilof JF, Ader HJ, Uitdehaag BM, Barkhof F, van Lier RA & Polman CH (2002): Seasonal variation in immune measurements and MRI markers of disease activity in MS. Neurology 58, 1077\u20131080.","journal-title":"Neurology"},{"key":"BF1601952_CR79","first-page":"5624","volume":"44","author":"HP Koeffler","year":"1984","unstructured":"Koeffler HP, Amatruda T, Ikekawa N, Kobayashi Y & DeLuca HF (1984): Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res. 44, 5624\u20135628.","journal-title":"Cancer Res."},{"key":"BF1601952_CR80","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/ki.1986.258","volume":"30","author":"R Kumar","year":"1986","unstructured":"Kumar R (1986): The metabolism and mechanism of action of 1,25-dihydroxyvitamin D3. Kidney Int. 30, 793\u2013803.","journal-title":"Kidney Int."},{"key":"BF1601952_CR81","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1212\/WNL.49.2_Suppl_2.S55","volume":"49","author":"K Lauer","year":"1997","unstructured":"Lauer K (1997): Diet and multiple sclerosis. Neurology 49, S55\u2013S61.","journal-title":"Neurology"},{"key":"BF1601952_CR82","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s004030050445","volume":"291","author":"B Lehmann","year":"1999","unstructured":"Lehmann B, Tiebel O & Meurer M (1999): Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents\u2014a preliminary study. Arch. Dermatol. Res. 291, 507\u2013510.","journal-title":"Arch. Dermatol. Res."},{"key":"BF1601952_CR83","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jbmr.5650070208","volume":"7","author":"JM Lemire","year":"1992","unstructured":"Lemire JM & Adams JS (1992): 1,25-Dihydroxyvitamin D3 inhibits the passive transfer of cellular immunity by a myelin basic protein-specific T cell clone. J. Bone Miner. Res. 7, 171\u2013177.","journal-title":"J. Bone Miner. Res."},{"key":"BF1601952_CR84","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1172\/JCI115072","volume":"87","author":"JM Lemire","year":"1991","unstructured":"Lemire JM & Archer DC (1991): 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J. Clin. Invest. 87, 1103\u20131107.","journal-title":"J. Clin. Invest."},{"key":"BF1601952_CR85","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1210\/endo.135.6.7988477","volume":"135","author":"JM Lemire","year":"1994","unstructured":"Lemire JM, Archer DC & Reddy GS (1994): 1,25-Dihydroxy-24-OXO-16ene-vitamin D3, a renal metabolite of the vitamin D analog 1,25-dihydroxy-16ene-vitamin D3, exerts immunosuppressive activity equal to its parent without causing hypercalcemia in vivo. Endocrinology 135, 2818\u20132821.","journal-title":"Endocrinology"},{"key":"BF1601952_CR86","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/edrv.22.4.0437","volume":"22","author":"P Lips","year":"2001","unstructured":"Lips P (2001): Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr. Rev. 22, 477\u2013501.","journal-title":"Endocr. Rev."},{"key":"BF1601952_CR87","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0221-8747(82)90021-2","volume":"4","author":"P Lips","year":"1982","unstructured":"Lips P, Netelenbos JC, Jongen MJ, van Ginkel FC, Althuis AL, van Schaik CL, van der Vijgh WJ, Vermeiden JP & van der Meer C (1982): Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metab. Bone Dis. Relat. Res. 4, 85\u201393.","journal-title":"Metab. Bone Dis. Relat. Res."},{"key":"BF1601952_CR88","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1210\/jcem-67-4-644","volume":"67","author":"P Lips","year":"1988","unstructured":"Lips P, Wiersinga A, van Ginkel FC, Jongen MJ, Netelenbos JC, Hackeng WH, Delmas PD & van der Vijgh WJ (1988): The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J. Clin. Endocrinol. Metab. 67, 644\u2013650.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF1601952_CR89","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1750-3639.1996.tb00854.x","volume":"6","author":"CF Lucchinetti","year":"1996","unstructured":"Lucchinetti CF, Bruck W, Rodriquez M & Lassmann H (1996): Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol. 6, 259\u2013274.","journal-title":"Brain Pathol."},{"key":"BF1601952_CR90","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(05)78933-9","volume":"351","author":"A Malabanan","year":"1998","unstructured":"Malabanan A, Veronikis IE & Holick MF (1998): Redefining vitamin D insufficiency. Lancet 351, 805\u2013806.","journal-title":"Lancet"},{"key":"BF1601952_CR91","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0165-5728(02)00396-X","volume":"134","author":"BD Mahon","year":"2003","unstructured":"Mahon BD, Gordon SA, Cruz J, Cosman F & Cantorna MT (2003): Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J. Neuroimmunol. 134, 128\u2013132.","journal-title":"J. Neuroimmunol."},{"key":"BF1601952_CR92","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0303-7207(85)90074-7","volume":"43","author":"SC Manolagas","year":"1985","unstructured":"Manolagas SC, Provvedini DM & Tsoukas CD (1985): Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Mol. Cell. Endocrinol. 43, 113\u2013122.","journal-title":"Mol. Cell. Endocrinol."},{"key":"BF1601952_CR93","volume-title":"McAlpine's Multiple Sclerosis","author":"CN Martyn","year":"1991","unstructured":"Martyn CN (1991): The epidemiology of multiple sclerosis. In McAlpine's Multiple Sclerosis, 2nd edn. WB Matthews ed. Edinburgh London Melbourne and New York: Churchill Livingstone."},{"key":"BF1601952_CR94","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1471-4914(02)02294-3","volume":"8","author":"C Mathieu","year":"2002","unstructured":"Mathieu C & Adorini L (2002): The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol. Med. 8, 174\u2013179.","journal-title":"Trends Mol. Med."},{"key":"BF1601952_CR95","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1359\/jbmr.2001.16.11.2057","volume":"16","author":"C Mathieu","year":"2001","unstructured":"Mathieu C, Van Etten E, Gysemans C, Decallonne B, Kato S, Laureys J, Depovere J, Valckx D & Bouillon R (2001): In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice. J. Bone Miner. Res. 16, 2057\u20132065.","journal-title":"J. Bone Miner. Res."},{"key":"BF1601952_CR96","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1210\/jcem-64-6-1165","volume":"64","author":"LY Matsuoka","year":"1987","unstructured":"Matsuoka LY, Wortsman J, MacLaughlin JA & Holick MF (1987): Sunscreens suppress cutaneous vitamin D3 synthesis. J. Clin. Endocrinol. Metab. 64, 1165\u20131168.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF1601952_CR97","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/1521-4141(200002)30:2<498::AID-IMMU498>3.0.CO;2-Q","volume":"30","author":"F Mattner","year":"2000","unstructured":"Mattner F, Smiroldo S, Galbiati F, Muller M, Di Lucia P, Poliani PL, Martino G, Panina-Bordignon P & Adorini L (2000): Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur. J. Immunol. 30, 498\u2013508.","journal-title":"Eur. J. Immunol."},{"key":"BF1601952_CR98","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/brain\/84.2.186","volume":"84","author":"D McAlpine","year":"1961","unstructured":"McAlpine D (1961): The benign form of multiple sclerosis: a study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease. Brain 84, 186\u2013203.","journal-title":"Brain"},{"key":"BF1601952_CR99","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(92)90682-2","volume":"93","author":"MJ McKenna","year":"1992","unstructured":"McKenna MJ (1992): Differences in vitamin D status between countries in young adults and the elderly. Am. J. Med. 93, 69\u201377.","journal-title":"Am. J. Med."},{"key":"BF1601952_CR100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0003-9861(02)00580-5","volume":"408","author":"TF Meehan","year":"2002","unstructured":"Meehan TF & DeLuca HF (2002): The vitamin D receptor is necessary for 1alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Arch. Biochem. Biophys. 408, 200\u2013204.","journal-title":"Arch. Biochem. Biophys."},{"key":"BF1601952_CR101","volume-title":"A Story of Nutritional Research. Effect of Some Dietary Factors on Bones and Nervous System","author":"E Mellanby","year":"1950","unstructured":"Mellanby E (1950): A Story of Nutritional Research. Effect of Some Dietary Factors on Bones and Nervous System. Baltimore: The Williams & Wilkins company."},{"key":"BF1601952_CR102","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00019052-199808000-00002","volume":"11","author":"P Monteyne","year":"1998","unstructured":"Monteyne P, Bureau JF & Brahic M (1998): Viruses and multiple sclerosis. Curr. Opin. Neurol. 11, 287\u2013291.","journal-title":"Curr. Opin. Neurol."},{"key":"BF1601952_CR103","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000059522","volume":"21","author":"C Montomoli","year":"2002","unstructured":"Montomoli C, Allemani C, Solinas G, Motta G, Bernardinelli L, Clemente S, Murgia BS, Ticca AF, Musu L, Piras ML, Ferrai R, Caria A, Sanna S & Porcu O (2002): An ecologic study of geographical variation in multiple sclerosis risk in central Sardinia, Italy. Neuroepidemiology 21, 187\u2013193.","journal-title":"Neuroepidemiology"},{"key":"BF1601952_CR104","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/03014469100001442","volume":"18","author":"TG Murrell","year":"1991","unstructured":"Murrell TG, Harbige LS & Robinson IC (1991): A review of the aetiology of multiple sclerosis: an ecological approach. Ann. Hum. Biol. 18, 95\u2013112.","journal-title":"Ann. Hum. Biol."},{"key":"BF1601952_CR105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0165-5728(01)00360-5","volume":"119","author":"FE Nashold","year":"2001","unstructured":"Nashold FE, Hoag KA, Goverman J & Hayes CE (2001): Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 119, 16\u201329.","journal-title":"J. Neuroimmunol."},{"key":"BF1601952_CR106","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0165-5728(99)00247-7","volume":"103","author":"FE Nashold","year":"2000","unstructured":"Nashold FE, Miller DJ & Hayes CE (2000): 1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. J. Neuroimmunol. 103, 171\u2013179.","journal-title":"J. Neuroimmunol."},{"key":"BF1601952_CR107","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/00005072-199608000-00006","volume":"55","author":"S Nataf","year":"1996","unstructured":"Nataf S, Garcion E, Darcy F, Chabannes D, Muller JY & Brachet P (1996): 1,25 Dihydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis. J. Neuropathol. Exp. Neurol. 55, 904\u2013914.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF1601952_CR108","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/ajcn\/71.6.1577","volume":"71","author":"AG Need","year":"2000","unstructured":"Need AG, Horowitz M, Morris HA & Nordin BC (2000): Vitamin D status: effects on parathyroid hormone and 1, 25-dihydroxyvitamin D in postmenopausal women. Am. J. Clin. Nutr. 71, 1577\u20131581.","journal-title":"Am. J. Clin. Nutr."},{"key":"BF1601952_CR109","unstructured":"Nellestijn J & Dekker K (1998): Wereldklimaat Informatie \u2014 Professioneel (Versie 2.0), De Bilt: Koninklijk Nederlands Meteorologisch Instituut."},{"key":"BF1601952_CR110","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jnr.490380212","volume":"38","author":"I Neveu","year":"1994","unstructured":"Neveu I, Naveilhan P, Menaa C, Wion D, Brachet P & Garab\u00e9dian M (1994): Synthesis of 1,25-dihydroxyvitamin D3 by rat brain macrophages in vitro. J. Neurosci. Res. 38, 214\u2013220.","journal-title":"J. Neurosci. Res."},{"key":"BF1601952_CR111","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.44.9.1687","volume":"44","author":"J Nieves","year":"1994","unstructured":"Nieves J, Cosman F, Herbert J, Shen V & Lindsay R (1994): High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 44, 1687\u20131692.","journal-title":"Neurology"},{"key":"BF1601952_CR112","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-5728(02)00099-1","volume":"127","author":"M Niino","year":"2002","unstructured":"Niino M, Kikuchi S, Fukazawa T, Yabe I & Tashiro K (2002): No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS. J. Neuroimmunol. 127, 177\u2013179.","journal-title":"J. Neuroimmunol."},{"key":"BF1601952_CR113","unstructured":"Norman AW (2000): Vitamin D and Milk. http:\/\/vitamind.ucr.edu\/milk.html."},{"key":"BF1601952_CR114","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0960-0760(92)90349-N","volume":"41","author":"AW Norman","year":"1992","unstructured":"Norman AW, Nemere I, Zhou LX, Bishop JE, Lowe KE, Maiyar AC, Collins ED, Taoka T, Sergeev I & Farach-Carson MC (1992): 1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J. Steroid. Biochem. Mol. Biol. 41, 231\u2013240.","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"BF1601952_CR115","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0021-9681(83)90142-X","volume":"36","author":"JE Norman","year":"1983","unstructured":"Norman JE, Kurtzke JF & Beebe GW (1983): Epidemiology of multiple sclerosis in US veterans: 2. Latitude, climate and the risk of multiple sclerosis. J. Chronic Dis. 36, 551\u2013559.","journal-title":"J. Chronic Dis."},{"key":"BF1601952_CR116","doi-asserted-by":"crossref","first-page":"A40","DOI":"10.1038\/399a040","volume":"399","author":"JH Noseworthy","year":"1999","unstructured":"Noseworthy JH (1999): Progress in determining the causes and treatment of multiple sclerosis. Nature 399, A40\u2013A47.","journal-title":"Nature"},{"key":"BF1601952_CR117","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2249.2000.01204.x","volume":"120","author":"L Overbergh","year":"2000","unstructured":"Overbergh L, Decallonne B, Valckx D, Verstuyf A, Depovere J, Laureys J, Rutgeerts O, Saint-Arnaud R, Bouillon R & Mathieu C (2000): Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin. Exp. Immunol. 120, 139\u2013146.","journal-title":"Clin. Exp. Immunol."},{"key":"BF1601952_CR118","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.4049\/jimmunol.103.6.1311","volume":"103","author":"PY Paterson","year":"1969","unstructured":"Paterson PY & Hanson MA (1969): Cyclophosphamide inhibition of experimental allergic encephalomyelitis and cellular transfer of the disease in Lewis rats. J. Immunol. 103, 1311\u20131316.","journal-title":"J. Immunol."},{"key":"BF1601952_CR119","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.164.5.2405","volume":"164","author":"G Penna","year":"2000","unstructured":"Penna G & Adorini L (2000): 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164, 2405\u20132411.","journal-title":"J. Immunol."},{"key":"BF1601952_CR120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.nu.11.070191.001201","volume":"11","author":"JW Pike","year":"1991","unstructured":"Pike JW (1991): Vitamin D3 receptors: structure and function in transcription. Annu. Rev. Nutr. 11, 189\u2013216.","journal-title":"Annu. Rev. Nutr."},{"key":"BF1601952_CR121","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1016\/S0021-9258(18)60729-X","volume":"263","author":"S Pillai","year":"1987","unstructured":"Pillai S, Bikle DD & Elias PM (1987): 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J. Biol. Chem. 263, 5390\u20135395.","journal-title":"J. Biol. Chem."},{"key":"BF1601952_CR122","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0300-483X(02)00257-3","volume":"181\u2013182","author":"AL Ponsonby","year":"2002","unstructured":"Ponsonby AL, McMichael A & van der Mei I (2002): Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 181\u2013182, 71\u201378.","journal-title":"Toxicology"},{"key":"BF1601952_CR123","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1126\/science.6310748","volume":"16","author":"DM Provvedini","year":"1983","unstructured":"Provvedini DM, Tsoukas CD, Deftos LJ & Manolagas SC (1983): 1,25-Dihydroxyvitamin D3 receptors in human leukocytes. Science 16, 1181\u20131183.","journal-title":"Science"},{"key":"BF1601952_CR124","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s100720170017","volume":"22","author":"M Pugliatti","year":"2001","unstructured":"Pugliatti M, Sotgiu S, Solinas G, Castiglia P & Rosati G (2001): Multiple sclerosis prevalence among Sardinians: further evidence against the latitude gradient theory. Neurol. Sci. 22, 163\u2013165.","journal-title":"Neurol. Sci."},{"key":"BF1601952_CR125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/135245850100700512","volume":"7","author":"G Ramsaransing","year":"2001","unstructured":"Ramsaransing G, Maurits N, Zwanikken C & De Keyser J (2001): Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review. Mult. Scler. 7, 345\u2013347.","journal-title":"Mult. Scler."},{"key":"BF1601952_CR126","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJM198904133201506","volume":"320","author":"H Reichel","year":"1989","unstructured":"Reichel H, Koeffler HP & Norman AW (1989): The role of vitamin D endocrine system in health and disease. N. Engl. Med. 320, 980\u2013991.","journal-title":"N. Engl. Med."},{"key":"BF1601952_CR127","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1128\/IAI.66.11.5314-5321.1998","volume":"66","author":"KA Rockett","year":"1998","unstructured":"Rockett KA, Brookes R, Udalova I, Vidal V, Hill A & Kwiatkowski D (1998): 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of mycobacterium tuberculosis in a human macrophage-like cell line. Infect. Immun. 66, 5314\u20135321.","journal-title":"Infect. Immun."},{"key":"BF1601952_CR128","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ana.83","volume":"49","author":"M Rovaris","year":"2001","unstructured":"Rovaris M, Comi G, Sormani MP, Wolinsky JS, Ladkani D & Filippi M (2001): Effects of seasons on magnetic resonance imaging\u2014measured disease activity in patients with multiple sclerosis. Ann. Neurol. 49, 415\u2013416.","journal-title":"Ann. Neurol."},{"key":"BF1601952_CR129","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2249.1996.tb08304.x","volume":"103","author":"SR Ruuls","year":"1996","unstructured":"Ruuls SR, Van Der Linden S, Sontrop K, Huitinga I & Dijkstra CD (1996): Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103, 467\u2013474.","journal-title":"Clin. Exp. Immunol."},{"key":"BF1601952_CR130","unstructured":"Scientific Committee on Food of the European Commission (SCF) (2002): Opinion of the Scientific Committee on Food on the tolerable upper intake level of vitamin D. Luxembourg: European Commission."},{"key":"BF1601952_CR131","doi-asserted-by":"crossref","first-page":"s7","DOI":"10.1007\/PL00022726","volume":"8","author":"SH Scharla","year":"1998","unstructured":"Scharla SH (1998): Prevalence of subclinical Vitamin D deficiency in different European countries. Osteoporos. Int. 8, s7\u2013s12.","journal-title":"Osteoporos. Int."},{"key":"BF1601952_CR132","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-0029-1211456","volume":"104","author":"SH Scharla","year":"1996","unstructured":"Scharla SH, Scheidt-Nave C, Leidig G, Woitge H, Wuster C, Seibel MJ & Ziegler R (1996): Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: a population-based study. Exp. Clin. Endocrinol. Diabetes 104, 289\u2013292.","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"BF1601952_CR133","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1359\/jbmr.1997.12.10.1552","volume":"12","author":"R St-Arnaud","year":"1997","unstructured":"St-Arnaud R, Messerlian S, Moir JM, Omdahl JL & Glorieux FH (1997): The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J. Bone Miner. Res. 12, 1552\u20131559.","journal-title":"J. Bone Miner. Res."},{"key":"BF1601952_CR134","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1079\/PNS19750022","volume":"34","author":"TCB Stamp","year":"1975","unstructured":"Stamp TCB (1975): Factors in human vitamin D nutrition and in the production and cure of classical rickets. Proc. Nutr. Soc. 34, 119\u2013130.","journal-title":"Proc. Nutr. Soc."},{"key":"BF1601952_CR135","first-page":"729","volume":"54","author":"JL Steckley","year":"2000","unstructured":"Steckley JL, Dyment DA, Sadovnick AD, Risch N, Hayes C & Ebers GC (2000): Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients. Canadian Collaborative Study Group. Neurology 54, 729\u2013732.","journal-title":"Canadian Collaborative Study Group. Neurology"},{"key":"BF1601952_CR136","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archneurpsyc.1953.02320250097011","volume":"69","author":"RL Swank","year":"1953","unstructured":"Swank RL (1953): Treatment of multiple sclerosis with low-fat diet. Arch. Neurol. Psych. 69, 91\u2013103.","journal-title":"Arch. Neurol. Psych."},{"key":"BF1601952_CR137","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1056\/NEJM195205082461901","volume":"246","author":"RL Swank","year":"1952","unstructured":"Swank RL, Lerstad O, Storm A & Barker J (1952): Multiple sclerosis in rural Norway: Its geographic and occupational incidence in relation to nutrition. N. Engl. J. Med. 246, 721\u2013728.","journal-title":"N. Engl. J. Med."},{"key":"BF1601952_CR138","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM199803193381201","volume":"338","author":"MK Thomas","year":"1998","unstructured":"Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL & Finkelstein JS (1998): Hypovitaminosis D in medical inpatients. N. Engl. J. Med. 338, 777\u2013783.","journal-title":"N. Engl. J. Med."},{"key":"BF1601952_CR139","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.4049\/jimmunol.161.7.3767","volume":"161","author":"EH Tran","year":"1998","unstructured":"Tran EH, Hoekstra K, van Rooijen N, Dijkstra CD & Owens T (1998): Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J. Immunol. 161, 3767\u20133775.","journal-title":"J. Immunol."},{"key":"BF1601952_CR140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-5728(99)00081-8","volume":"98","author":"BD Trapp","year":"1999","unstructured":"Trapp BD, B\u00f6 L, M\u00f6rk S & Chang A (1999): Pathogenesis of tissue injury in MS lesions. J. Neuroimmunol. 98, 49\u201356.","journal-title":"J. Neuroimmunol."},{"issue":"Suppl 1","key":"BF1601952_CR141","first-page":"S76","volume":"51","author":"H Van den Berg","year":"1997","unstructured":"Van den Berg H (1997): Bioavailability of vitamin D. Eur. J. Clin. Nutr. 51 (Suppl 1), S76\u2013S79.","journal-title":"Eur. J. Clin. Nutr."},{"key":"BF1601952_CR142","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000054783","volume":"20","author":"IA Van Der Mei","year":"2001","unstructured":"Van Der Mei IA, Ponsonby AL, Blizzard L & Dwyer T (2001): Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 20, 168\u2013174.","journal-title":"Neuroepidemiology"},{"key":"BF1601952_CR143","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/bmj.327.7410.316","volume":"327","author":"IA Van Der Mei","year":"2003","unstructured":"Van Der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Simmons R, Taylor BV, Butzkueven H & Kilpatrick T (2003): Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ 327, 316.","journal-title":"BMJ"},{"key":"BF1601952_CR144","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S8756-3282(03)00030-9","volume":"32","author":"E Van Etten","year":"2003","unstructured":"Van Etten E, Branisteanu DD, Overbergh L, Bouillon R, Verstuyf A & Mathieu C (2003): Combination of a 1,25-dihydroxyvitamin D(3) analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone. Bone 32, 397\u2013404.","journal-title":"Bone"},{"key":"BF1601952_CR145","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1097\/00007890-200005150-00032","volume":"69","author":"E Van Etten","year":"2000","unstructured":"Van Etten E, Branisteanu DD, Verstuyf A, Waer M, Bouillon R & Mathieu C (2000): Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants. Transplantation 69, 1932\u20131942.","journal-title":"Transplantation"},{"key":"BF1601952_CR146","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0074-7696(08)62137-3","volume":"178","author":"JM Van Noort","year":"1998","unstructured":"Van Noort JM & Amor S (1998): Cell biology of autoimmune diseases. Int. Rev. Cytol. 178, 127\u2013206.","journal-title":"Int. Rev. Cytol."},{"key":"BF1601952_CR147","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00041552-199807000-00008","volume":"7","author":"A Verstuyf","year":"1998","unstructured":"Verstuyf A, Segaert S, Verlinden L, Casteels K, Bouillon R & Mathieu C (1998): Recent developments in the use of vitamin D analogues. Curr. Opin. Nephrol. Hypertens. 7, 397\u2013403.","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BF1601952_CR148","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/ajcn\/69.5.842","volume":"69","author":"R Vieth","year":"1999","unstructured":"Vieth R (1999): Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am. J. Clin. Nutr. 69, 842\u2013856.","journal-title":"Am. J. Clin. Nutr."},{"key":"BF1601952_CR149","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/ajcn\/73.2.288","volume":"73","author":"R Vieth","year":"2001","unstructured":"Vieth R, Chan PR & MacFarlane GD (2001): Efficacy and safety of vitamin D3 intake exceeding the lowest observed effect level. Am. J. Clin. Nutr. 73, 288\u2013294.","journal-title":"Am. J. Clin. Nutr."},{"key":"BF1601952_CR150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1210\/jc.2002-021064","volume":"88","author":"R Vieth","year":"2003","unstructured":"Vieth R, Ladak Y & Walfish PG (2003): Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J. Clin. Endocrinol. Metab. 88, 185\u2013191.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF1601952_CR151","first-page":"719","volume":"13","author":"MR Walters","year":"1992","unstructured":"Walters MR (1992): Newly identified actions of the vitamin D endocrine system. Endocr. Rev. 13, 719\u2013764.","journal-title":"Endocr. Rev."},{"key":"BF1601952_CR152","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1210\/jcem-68-5-882","volume":"68","author":"AR Webb","year":"1989","unstructured":"Webb AR, DeCosta BR & Holick MF (1989): Sunlight regulates the cutaneous production of vitamin D3 by causing its photodegradation. J. Clin. Endocrinol. Metab. 68, 882\u2013887.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF1601952_CR153","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.nu.08.070188.002111","volume":"8","author":"AR Webb","year":"1988","unstructured":"Webb AR & Holick MF (1988): The rol of sunlight in the cutaneous production of vitamin D3. Annu. Rev. Nutr. 8, 375\u2013399.","journal-title":"Annu. Rev. Nutr."},{"key":"BF1601952_CR154","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1043-2760(00)00317-9","volume":"11","author":"P White","year":"2000","unstructured":"White P & Cooke N (2000): The Multifunctional Properties and Characteristics of Vitamin D-binding Protein. Trends Endocrinol. Metab. 11, 320\u2013327.","journal-title":"Trends Endocrinol. Metab."},{"key":"BF1601952_CR155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-5728(99)00212-X","volume":"100","author":"DO Willenborg","year":"1999","unstructured":"Willenborg DO, Staykova MA & Cowden WB (1999): Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review. J. Neuroimmun. 100, 21\u201335.","journal-title":"J. Neuroimmun."},{"key":"BF1601952_CR156","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/ajcn\/72.3.690","volume":"72","author":"J Wortsman","year":"2000","unstructured":"Wortsman J, Matsuoka LY, Chen TC, Lu Z & Holick MF (2000): Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 72, 690\u2013693.","journal-title":"Am J Clin Nutr."},{"key":"BF1601952_CR157","doi-asserted-by":"crossref","first-page":"12971","DOI":"10.1074\/jbc.274.19.12971","volume":"274","author":"Y Yanagi","year":"1999","unstructured":"Yanagi Y, Suzawa M, Kawabata M, Miyazono K, Yanagisawa J & Kato S (1999): Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins. J. Biol. Chem. 274, 12971\u201312974.","journal-title":"J. Biol. Chem."},{"key":"BF1601952_CR158","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.283.5406.1317","volume":"283","author":"J Yanagisawa","year":"1999","unstructured":"Yanagisawa J, Yanagi Y, Masuhiro Y, Suzawa M, Watanabe M, Kashiwagi K, Toriyabe T, Kawabata M, Miyazono K & Kato S (1999): Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283, 1317\u20131321.","journal-title":"Science"},{"key":"BF1601952_CR159","first-page":"888","volume":"86","author":"D Zehnder","year":"2001","unstructured":"Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM & Hewison M (2001): Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J. Clin. Endocrinol. Metab. 86, 888\u2013894.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF1601952_CR160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-5728(95)00158-1","volume":"64","author":"W Zhao","year":"1996","unstructured":"Zhao W, Tilton RG, Corbett JA, McDaniel ML, Misko TP, Williamson JR, Cross AH & Hickey WF (1996): Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J. Neuroimmunol. 64, 123\u2013133.","journal-title":"J. Neuroimmunol."},{"key":"BF1601952_CR161","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.ejcn.1600591","volume":"52","author":"A Zittermann","year":"1998","unstructured":"Zittermann A, Scheld K & Stehle P (1998): Seasonal variations in vitamin D status and calcium absorption do not influence bone turnover in young women. Eur. J. Clin. Nutr. 52, 501\u2013506.","journal-title":"Eur. J. Clin. Nutr."},{"key":"BF1601952_CR162","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.epirev.a018033","volume":"22","author":"JM Zmuda","year":"2000","unstructured":"Zmuda JM, Cauley JA & Ferrell RE (2000): Molecular epidemiology of vitamin D receptor gene variants. Epidemiol. Rev. 22, 203\u2013217.","journal-title":"Epidemiol. Rev."}],"container-title":["European Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1601952.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1601952","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1601952.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T06:02:51Z","timestamp":1682661771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1601952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,31]]},"references-count":162,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8,1]]}},"alternative-id":["BF1601952"],"URL":"https:\/\/doi.org\/10.1038\/sj.ejcn.1601952","relation":{},"ISSN":["0954-3007","1476-5640"],"issn-type":[{"value":"0954-3007","type":"print"},{"value":"1476-5640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,31]]},"assertion":[{"value":"9 June 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2003","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2004","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2004","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}